Author

Xianglin Shi

University of Notre Dame

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Aggie Law· 1 shared Guangyuan Frank Li· 1 shared Jianneng LiiD· 1 shared Josie Behm· 1 shared Lindsey Phelan· 1 shared Samual Adams· 1 shared Therese Lewis· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aggie Law

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

5β-Dihydrotestosterone reveals a mutant androgen receptor vulnerability in prostate cancer

Samual Adams, Lindsey Phelan, Therese Lewis, Josie Behm, Aggie Law, Xianglin Shi, Guangyuan Frank Li, Jianneng Li

This paper evaluates 5β-Dihydrotestosterone (5β-DHT) as a potential alternative to testosterone in bipolar androgen therapy (BAT) for prostate cancer, showing it activates AR signaling in mutant AR contexts and suppresses tumor growth with fewer side effects.

bioRxiv · Jul 15, 2026 · PreprintCancer Biology